Healthcare & Life Sciences
MigVax
Israelwww.migvax.com/
MigVax is a series b startup based in Israel. 1 investor tracked.
activeseries-a
series-a
Stage
1
Investors
About MigVax
MigVax is a startup based in Israel. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
MigVax develops an oral COVID-19 subunit vaccine that induces mucosal, humoral, and cellular immunity through a protein-based tablet formulation designed for easy administration and improved logistical stability.
Explore MigVax's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.